Article

Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide

2020-10-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Immunotherapy has received an increasing amount of attention in the field of multiple myeloma treatment because it has low-level toxicity however, there are very few studies on immunotherapy drug resistance. This study aimed to initially explore the relevant factors and possible mechanisms of immunotherapy drugs Elotuzumab (Elo) and Lenalidomides’ resistance bot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 81b572cd-4528-51fd-92f7-78f3b8bfcb00
DOI: 10.21203/rs.3.rs-61639/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and LenalidomideDOI 10.21203/rs.3.rs-61639/v1Read

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanismsSemantic proximity Read

Targeting NF-κB Signaling for Multiple MyelomaSemantic proximity Read

Role of micro-RNAs in drug resistance of multiple myelomaSemantic proximity Read

IL-10R Inhibition Reprograms Tumor-Associated Macrophages and Reverses Drug Resistance in Multiple MyelomaSemantic proximity Read

IMiD Resistance in Multiple Myeloma: Current Understanding of the Underpinning Biology and Clinical ImpactSemantic proximity Read

Tumor and microenvironmental mechanisms of resistance to immunomodulatory drugs in multiple myelomaSemantic proximity Read

Small-molecule HDAC and Akt Inhibitors Suppress Tumor Growth and Enhance Immunotherapy in Multiple MyelomaSemantic proximity Read

Impact of Clonal Hematopoiesis on the Carcinogenic Process of Multiple MyelomaSemantic proximity Read

SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myelomaSemantic proximity Read

Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4Semantic proximity Read

Potential role of exosome-associated microRNA panels and <i>in vivo</i> environment to predict drug resistance for patients with multiple myelomaSemantic proximity Read

Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patientsSemantic proximity Read